Platelet glycoprotein IIb/IIIa receptor blockade in coronary artery disease
<p>Abstract</p> <p>Glycoprotein IIb/IIIa inhibitors represent a new promising class of antiplatelet medications. Their use in acute coronary syndromes and for patients undergoing percutaneous coronary intervention has been the subject of a number of large controlled trials using both the intravenous...
Salvato in:
| Autori principali: | , |
|---|---|
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
BMC
2001-07-01
|
| Serie: | Current Controlled Trials in Cardiovascular Medicine |
| Soggetti: | |
| Accesso online: | http://cvm.controlled-trials.com/content/2/4/171 |
| Tags: |
Nessun Tag, puoi essere il primo ad aggiungerne!!
|